Ofelia Álvarez

4.6k total citations · 1 hit paper
73 papers, 2.8k citations indexed

About

Ofelia Álvarez is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ofelia Álvarez has authored 73 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Genetics, 48 papers in Hematology and 14 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ofelia Álvarez's work include Hemoglobinopathies and Related Disorders (57 papers), Iron Metabolism and Disorders (40 papers) and Blood groups and transfusion (14 papers). Ofelia Álvarez is often cited by papers focused on Hemoglobinopathies and Related Disorders (57 papers), Iron Metabolism and Disorders (40 papers) and Blood groups and transfusion (14 papers). Ofelia Álvarez collaborates with scholars based in United States, Jamaica and Switzerland. Ofelia Álvarez's co-authors include Dima Hamideh, David F. Carmichael, Yves A. DeClerck, Julie Kanter, Abdullah Kutlar, Kenneth I. Ataga, Russell E. Ware, Darla Liles, Rodolfo Delfini Cançado and João Ricardo Friedrisch and has published in prestigious journals such as New England Journal of Medicine, Blood and PLoS ONE.

In The Last Decade

Ofelia Álvarez

68 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease

2016 595 citations Kenneth I. Ataga, Abdullah Kutlar et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ofelia Álvarez United States	27	1.8k	1.5k	663	349	227	73	2.8k
Isabelle Thuret France	27	726 0.4×	1.2k 0.8×	596 0.9×	359 1.0×	174 0.8×	113	2.4k
Hannah Tamary Israel	33	1.1k 0.6×	1.9k 1.3×	258 0.4×	660 1.9×	862 3.8×	154	3.6k
Hans‐Jochem Kolb Germany	39	842 0.5×	3.2k 2.1×	353 0.5×	746 2.1×	127 0.6×	175	5.9k
Paolo de Fabritiis Italy	32	814 0.5×	1.8k 1.2×	203 0.3×	840 2.4×	88 0.4×	199	3.2k
Rina Zaizov Israel	33	740 0.4×	935 0.6×	357 0.5×	931 2.7×	676 3.0×	185	3.5k
M L Hancock United States	27	383 0.2×	1.4k 0.9×	917 1.4×	729 2.1×	92 0.4×	41	3.3k
Claire Galambrun France	29	483 0.3×	1.3k 0.8×	489 0.7×	312 0.9×	217 1.0×	79	2.5k
Hyo Seop Ahn South Korea	27	573 0.3×	729 0.5×	308 0.5×	700 2.0×	95 0.4×	162	2.4k
Naynesh Kamani United States	27	647 0.4×	1.5k 1.0×	581 0.9×	248 0.7×	158 0.7×	77	2.8k
Giovanna Meloni Italy	40	1.0k 0.6×	3.7k 2.5×	395 0.6×	1.3k 3.8×	53 0.2×	159	5.6k

Countries citing papers authored by Ofelia Álvarez

Since Specialization

Citations

This map shows the geographic impact of Ofelia Álvarez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ofelia Álvarez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ofelia Álvarez more than expected).

Fields of papers citing papers by Ofelia Álvarez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ofelia Álvarez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ofelia Álvarez. The network helps show where Ofelia Álvarez may publish in the future.

Co-authorship network of co-authors of Ofelia Álvarez

This figure shows the co-authorship network connecting the top 25 collaborators of Ofelia Álvarez. A scholar is included among the top collaborators of Ofelia Álvarez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ofelia Álvarez. Ofelia Álvarez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Osunkwo, Ifeyinwa, Cheryl Courtlandt, Patience H. White, et al.. (2024). Results of a healthcare transition learning collaborative for emerging adults with sickle cell disease: the ST3P-UP study transition quality improvement collaborative. BMJ Quality & Safety. 34(11). 747–757. 3 indexed citations

Álvarez, Ofelia, et al.. (2023). Implementation of hospital-based sickle cell newborn screening and follow-up programs in Haiti. Blood Advances. 8(1). 14–22. 4 indexed citations

Álvarez, Ofelia, et al.. (2023). Pain or Weakness? An Immunocompromised Patient Presenting with Inability to Walk. Clinical Immunology. 250. 109398–109398.

Álvarez, Ofelia, et al.. (2023). Successful quality improvement project to increase hydroxyurea prescriptions for children with sickle cell anaemia. BMJ Quality & Safety. 32(10). 608–616. 1 indexed citations

Hulbert, Monica L., Deepa Manwani, Emily Riehm Meier, et al.. (2022). Consensus definition of essential, optimal, and suggested components of a pediatric sickle cell disease center. Pediatric Blood & Cancer. 70(1). e29961–e29961. 13 indexed citations

Daak, Ahmed, Carlton Dampier, Beng Fuh, et al.. (2018). Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial). Blood Advances. 2(15). 1969–1979. 31 indexed citations

Kutlar, Abdullah, Julie Kanter, Darla Liles, et al.. (2018). Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: A SUSTAIN study analysis. American Journal of Hematology. 94(1). 55–61. 88 indexed citations

Ataga, Kenneth I., Abdullah Kutlar, Julie Kanter, et al.. (2016). Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease. New England Journal of Medicine. 376(5). 429–439. 595 indexed citations breakdown →

Álvarez, Ofelia, et al.. (2014). Quantification of Sickle Cells in the Peripheral Smear as a Marker of Disease Severity. Fetal and Pediatric Pathology. 34(3). 149–154. 15 indexed citations

10.

Álvarez, Ofelia, Nancy A. Yovetich, John P. Scott, et al.. (2013). Pain and other non‐neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: Results from the SWiTCH clinical trial. American Journal of Hematology. 88(11). 932–938. 39 indexed citations

11.

Thornburg, Courtney D., Beatrice Files, Zhaoyu Luo, et al.. (2012). Impact of hydroxyurea on clinical events in the BABY HUG trial. Blood. 120(22). 4304–4310. 184 indexed citations

12.

Álvarez, Ofelia, et al.. (2012). Ventricular Structure and Function in Children With Sickle Cell Disease Using Conventional and Tissue Doppler Echocardiography. The American Journal of Cardiology. 109(9). 1358–1364. 34 indexed citations

13.

Álvarez, Ofelia, Gabriela Lopez‐Mitnik, & Gastón Zilleruelo. (2008). Short‐term follow‐up of patients with sickle cell disease and albuminuria. Pediatric Blood & Cancer. 50(6). 1236–1239. 39 indexed citations

14.

Sola, Juan E., Juan C. Gutierrez, William R. Thompson, et al.. (2008). Wilms' tumor, pancreatic islet cell carcinoma, and pheochromocytoma in a child. Journal of Pediatric Surgery. 43(3). e25–e29. 1 indexed citations

15.

Sola, Juan E., et al.. (2007). Primary renal botryoid rhabdomyosarcoma: diagnosis and outcome. Journal of Pediatric Surgery. 42(12). e17–e20. 7 indexed citations

16.

Álvarez, Ofelia, et al.. (2006). Serum cystatin C levels in children with sickle cell disease. Pediatric Nephrology. 21(4). 533–537. 30 indexed citations

17.

Álvarez, Ofelia, et al.. (2005). Early blood transfusions protect against microalbuminuria in children with sickle cell disease. Pediatric Blood & Cancer. 47(1). 71–76. 65 indexed citations

18.

Cleve, Lois Van, Elizabeth Bossert, Pauline C. Beecroft, et al.. (2004). The Pain Experience of Children With Leukemia During the First Year After Diagnosis. Nursing Research. 53(1). 1–10. 84 indexed citations

19.

Álvarez, Ofelia, Ingrid Kjellin, & Craig W. Zuppan. (2004). Thoracic Lymphangiomatosis in a Child. Journal of Pediatric Hematology/Oncology. 26(2). 136–141. 45 indexed citations

20.

Álvarez, Ofelia, David F. Carmichael, & Yves A. DeClerck. (1990). Inhibition of Collagenolytic Activity and Metastasis of Tumor Cells by a Recombinant Human Tissue Inhibitor of Metalloproteinases. JNCI Journal of the National Cancer Institute. 82(7). 589–595. 197 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact